Baxter Gains Expanded CE Marking for Hemopatch

Baxter International has received expanded CE marking for a surgical patch for closing dural defects.

Surgeons in the EU are now permitted to use Hemopatch to control bleeding, seal suture lines and replace dura mater during neurosurgery.

Since 2013, the patch has been approved in the EU as a hemostatic device if traditional methods are either futile or impractical. — Anisa Jibrell